Literature DB >> 3316560

Diagnosis of pre-type I diabetes.

H P Chase1, M A Voss, N Butler-Simon, S Hoops, D O'Brien, M J Dobersen.   

Abstract

Islet cell antibodies were found in 71 of 1169 first-degree relatives (6.1%) from 448 families who had a proband with type I diabetes. Seven children have since become insulin dependent. All had islet cell antibodies and were followed up prospectively with measurement of first-phase insulin production during intravenous glucose tolerance testing. In this group the statistical probability of developing type I diabetes within 12 months with 95% confidence was found to be 59% to 100% when the first-phase insulin secretion was less than 25 microU/mL. The identification of the prediabetes time period should allow an opportunity for intervention in the underlying disease process to determine if the onset of type I diabetes can be altered.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3316560     DOI: 10.1016/s0022-3476(87)80192-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

1.  Is a low insulin response to intravenous glucose a marker of type 1 (insulin-dependent) insulin?

Authors:  P P Razenberg
Journal:  Diabetologia       Date:  1989-02       Impact factor: 10.122

2.  Natural history of preclinical IDDM in high risk siblings. Childhood Diabetes in Finland Study Group.

Authors:  M Knip; P Vähäsalo; J Karjalainen; R Lounamaa; H K Akerblom
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

3.  Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients.

Authors:  P Vardi; L Crisa; R A Jackson
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

4.  Aspartic acid at position 57 of the HLA-DQ beta chain is protective against future development of insulin-dependent (type 1) diabetes mellitus.

Authors:  B O Boehm; B Manfras; C Rosak; K Schöffling; M Trucco
Journal:  Klin Wochenschr       Date:  1991-02-26

5.  Islet cell antibodies in normal French schoolchildren.

Authors:  C Lévy-Marchal; J Tichet; I Fajardy; X F Gu; F Dubois; P Czernichow
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

Review 6.  Staging the progression to type 1 diabetes with prediagnostic markers.

Authors:  Jay M Sosenko
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-08       Impact factor: 3.243

7.  Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children.

Authors:  M Landin-Olsson; J P Palmer; A Lernmark; L Blom; G Sundkvist; L Nyström; G Dahlquist
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

8.  Indications for a more aggressive disease process in newly diagnosed insulin-dependent diabetic children in northern than in southern Europe.

Authors:  U Samuelsson; J Ludvigsson; G F Bottazzo; M Shattock; S Adolfsson; D Becker; E Cacciari; F Chiarelli; G Chiumello; I Deschamps
Journal:  Acta Diabetol       Date:  1994-06       Impact factor: 4.280

9.  Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide.

Authors:  R B Elliott; H P Chase
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

Review 10.  The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1.

Authors:  Jay M Sosenko; Jay S Skyler; Kevan C Herold; Jerry P Palmer
Journal:  Diabetes       Date:  2012-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.